The size of the APAC cold plasma market was valued at USD 0.35 billion in 2022. It is estimated to grow at a CAGR of 18.3% from 2022 to 2027 and be valued at USD 0.82 billion by 2027.
The cold plasma market in the Asia-Pacific is expected to grow rapidly in the global market among all the regions. Increasing demand for frozen foods and increasing textile manufacturing will support market growth during the forecast period.
Additionally, rising utilization levels of cold plasma for therapeutics, growing incidence of hospital-acquired infections, and introducing of new and innovative cancer treatment procedures are majorly accelerating the cold plasma market's growth in the APAC region. The increasing aging population suffering from diabetes is another crucial factor favoring the market growth.
High costs, lack of reimbursement policies, side effects associated with cold plasma, and increased capital investments required for executing cold plasma technology hinder market growth in this region.
This research report on the APAC cold plasma market has been segmented & sub-segmented into the following categories:
APAC is expected to be the fastest-growing market based on the region due to the increasing textile manufacturing and demand for frozen foods. In addition, developing countries like China and India are expected to boost the market.
Due to its increasing infrastructural and economic activities, China is estimated to lead the APAC cold plasma market during the forecast period. In addition, escalating R&D investments in China's healthcare sector are estimated to showcase a positive effect on the cold plasma market in this country.
The Indian Cold Plasma market is projected to grow at a promising CAGR during the forecast period with the growing utilization of equipment for cold plasma, the rising pharmaceutical industry, and increasing medical research for treatments like lung cancer, skin, and breast cancer.
The Cold Plasma market in Japan is projected to have notable growth during the forecast period. Factors like medical applications include improving tissue repair, managing blood loss, and destroying cancer cells.
KEY MARKET PLAYERS:
Companies dominating the APAC cold plasma market profiled in the report are Enercon Industries Corporation, Henniker Plasma, ADTEC Plasma Technology Co. Ltd., Europlasma NV, Neoplas Tools GmbH, P2i Limited, Nordson Corporation, Plasmatreat GmbH, Vetaphone A/S, and Tantec A/S.
The cold plasma market in APAC is predicted to grow at a CAGR of 18.3% from 2022 to 2027.
The rising demand for packaged foods, rising awareness about the benefits of cold plasma technology in healthcare, and growing applications of cold plasma in the electronics industry are some of the major factors boosting the cold plasma market in the Asia-Pacific region.
Nordson Corporation, Plasmatreat GmbH, Tantec A/S, and Enercon Industries Corporation are some of the notable companies in the APAC cold plasma market.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com